Cas:69976-08-5 3-(8-chloroquinoline-4-yl)acrylic acid manufacturer & supplier

Chemical Name:3-(8-chloroquinoline-4-yl)acrylic acid

CAS.NO:69976-08-5

Synonyms:3-(8-chloroquinoline-4-yl)acrylic acid

Molecular Formula:C₁₂H₈ClNO₂

Molecular Weight:233.65000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:438.5ºC at 760 mmHg

Density:1.421g/cm3

Index of Refraction:1.714

PSA:50.19000

Exact Mass:233.02400

LogP:2.98600

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(8-chloroquinoline-4-yl)acrylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(8-chloroquinoline-4-yl)acrylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(8-chloroquinoline-4-yl)acrylic acid Use and application,3-(8-chloroquinoline-4-yl)acrylic acid technical grade,usp/ep/jp grade.

Related News: It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. 3-(8-chloroquinoline-4-yl)acrylic acid manufacturer It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. 3-(8-chloroquinoline-4-yl)acrylic acid supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 3-(8-chloroquinoline-4-yl)acrylic acid vendor This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. 3-(8-chloroquinoline-4-yl)acrylic acid factory Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue.